CLDX EBITDA Growth
Celldex Therapeutics Inc · EBITDA Growth
CLDX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.28%period ending
CLDX Quarterly EBITDA YoY % (500.00% → -30.28%)
Year-over-year change
High-resolution chart · PNG
CLDX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -30.2798% | |
| -47.0479% | |
| -74.0626% | |
| -60.2032% | |
| -59.0156% | |
| -65.2327% | |
| -34.6398% | |
| -10.2472% | |
| -17.8142% | |
| -11.8666% | |
| -33.1371% | |
| -43.5798% | |
| -10.248% | |
| -24.5975% | |
| -30.3211% | |
| -41.3577% | |
| -117.2733% | |
| -49.4181% | |
| -108.3298% | |
| -44.1064% | |
| -4.8021% | |
| -34.121% | |
| 17.5082% | |
| -0.5412% | |
| 2.244% | |
| 13.5795% | |
| 11.7052% | |
| 8.0352% | |
| 48.0075% | |
| 40.6848% | |
| 47.5322% | |
| 37.863% | |
| 12.6952% | |
| 25.7287% | |
| 15.2444% | |
| 23.1654% | |
| 15.0127% | |
| 13.2156% | |
| 9.2272% | |
| 7.3746% | |
| 1.1452% | |
| -15.4811% | |
| -3.7404% | |
| -6.325% | |
| -14.6899% | |
| -6.7443% | |
| -46.0025% | |
| -30.8337% | |
| -54.5708% | |
| -68.807% | |
| -34.9194% | |
| -61.0361% | |
| -42.9631% | |
| -36.1855% | |
| -42.6447% | |
| -38.3999% | |
| -38.9892% | |
| -42.2036% | |
| -140.5068% | |
| -29.3756% | |
| -13.8118% | |
| -23.4131% | |
| 335.1709% | |
| -21.3288% | |
| 0.6143% | |
| 0.3712% | |
| -63.3038% | |
| 17.033% | |
| 16.4503% | |
| 0.1996% | |
| -53.0161% | |
| -123.3856% | |
| -426.732% | |
| -75.7384% | |
| 27.4998% | |
| 37.9607% | |
| 68.931% | |
| -65.9722% | |
| -75.95% | |
| -37.0601% | |
| -35.1497% | |
| 48.5506% | |
| -9.2569% | |
| -20.1682% | |
| -20.6195% | |
| -203.3736% | |
| -24.2338% | |
| -98.0363% | |
| -30.5868% | |
| 49.4374% | |
| 15.7659% | |
| -286,183.3333% | |
| 44.3623% | |
| 34.9546% | |
| 51.0328% | |
| 99.9901% | |
| 11.8409% | |
| -12.9209% | |
| -35.0538% | |
| -49.9342% |